Harrow (HROW) Market Capitalization (2010 - 2026)
Harrow (HROW) posted Market Capitalization of $1.6 billion for Q2 2026, up 21.14% on a QoQ basis from $1.3 billion in Q1 2026, and up 41.98% year-over-year from $1.1 billion in Q2 2025.
Analysis
Harrow (HROW) Market Capitalization (2010 - 2026) Analysis & Trends
Harrow has reported Market Capitalization for 17 years, with the latest figure at $1.6 billion in Q2 2026.
- On a quarterly basis, Market Capitalization rose 41.98% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 41.98% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 52.64% from the prior year.
- Market Capitalization was $1.6 billion for Q2 2026 at Harrow, up from $1.3 billion in the prior quarter.
- The five-year high for Market Capitalization was $1.8 billion in Q4 2025, with the low at $184.4 million in Q1 2022.
- Average Market Capitalization over 5 years is $880.6 million, with a median of $688.6 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Market Capitalization jumped 244.99% in 2023, then dropped 26.4% in 2024.
- Over 5 years, Market Capitalization stood at $441.3 million in 2022, then declined by 10.75% to $393.9 million in 2023, then soared by 203.42% to $1.2 billion in 2024, then soared by 52.64% to $1.8 billion in 2025, then slipped by 12.73% to $1.6 billion in 2026.
- The last three Market Capitalization figures came in at $1.6 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.78 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 948.40 Mn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.60 Bn |
| Jun 30, 2024 | 741.17 Mn |
| Mar 31, 2024 | 468.09 Mn |
| Dec 31, 2023 | 393.88 Mn |
| Sep 30, 2023 | 504.64 Mn |
| Jun 30, 2023 | 576.47 Mn |
| Mar 31, 2023 | 635.99 Mn |
| Dec 31, 2022 | 441.35 Mn |
| Sep 30, 2022 | 326.79 Mn |
| Jun 30, 2022 | 197.07 Mn |
| Mar 31, 2022 | 184.35 Mn |
| Dec 31, 2021 | 232.44 Mn |
| Sep 30, 2021 | 244.55 Mn |